Order
      
      113473-97-5
      
        2,4,6,8-Nonatetraenamide,N,N-diethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-,(Z,E,E,E)-
      
    
    
    
    
    
    
    
      
        Order
      
      176435-10-2
      
        8-37-Glucagon-like peptide I (human),N-[3-(1H-imidazol-4-yl)-1- oxopropyl]-26-L-arginine-34-[N6-(1- oxooctyl)-L-lysine]-
      
    
    
    
      
        Order
      
      113470-94-3
      
        1,3-Benzodioxol-5-ol,6-[[3-(1,1-dimethylethyl)-2-hydroxyphenyl](4-methoxyphenyl)methyl]-
      
    
    
    
      
        Order
      
      113464-52-1
      
        1H,10H-Furo[3',4':4a,5]naphtho[2,1-c]pyran-1,5,8(4bH,7aH)-trione,3-(3-furanyl)-3,4,4a,11,12,12a-hexahydro-11-hydroxy-4a-methyl-, [3S-(3a,4ab,4ba,7aa,10aS*,11a,12ab)]-
      
    
    
    
    
                    
  
  
  
  
  
  
  
  
                113463-18-6,113463-19-7,113464-52-1,113464-78-1,113464-95-2,113466-23-2 Supplier | KINGPHARM.GROUP
            CMO CDMO service. KINGPHARM.GROUP supply 113463-18-6,113463-19-7,113464-52-1,113464-78-1,113464-95-2,113466-23-2 and related compounds.
            
                    113464-78-1
                    113463-18-6
                    113464-52-1
                    113463-19-7
                    113464-95-2
                    113466-23-2